IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

(2018) Paul M Ridker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

HDL in CKD—The Devil Is in the Detail

(2018) Florian Kronenberg   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

(2017) A. Michael Lincoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cholesterol efflux capacity: An introduction for clinicians

(2016) Malcolm Anastasius et al.   AMERICAN HEART JOURNAL

Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis

(2016) Francis O'Neill et al.   HEART

High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation

(2016) Seth G. Thacker et al.   IMMUNOLOGY

IL-1 Inhibition and Vascular Function in CKD

(2016) Kristen L. Nowak et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis

(2016) Michelle J. Ormseth et al.   Arthritis & Rheumatology

Dysfunctional high-density lipoproteins in children with chronic kidney disease

(2015) Ryohei Kaseda et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

HDL abnormalities in nephrotic syndrome and chronic kidney disease

(2015) Nosratola D. Vaziri   Nature Reviews Nephrology

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis

(2015) K. P. Liao et al.   Journal of the American Heart Association

Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism

(2015) Nicoletta Ronda et al.   Arthritis & Rheumatology

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

(2015) Danish Saleheen et al.   Lancet Diabetes & Endocrinology

Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?

(2014) A. Abbate et al.   EUROPEAN HEART JOURNAL

Anti-inflammatory therapies for cardiovascular disease

(2014) P. M. Ridker et al.   EUROPEAN HEART JOURNAL

Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients

(2014) Neha Singh et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients

(2014) Adriana M. Hung et al.   JOURNAL OF NEPHROLOGY

HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction

(2014) S. Zewinger et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype

(2014) R. Shroff et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

(2014) Anand Rohatgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]

(2013) Antonio Abbate et al.   AMERICAN JOURNAL OF CARDIOLOGY

High-Density Lipoproteins

(2013) Wijtske Annema et al.   CIRCULATION JOURNAL

Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2

(2013) Thimoteus Speer et al.   IMMUNITY

ANCOVA Versus CHANGE From Baseline in Nonrandomized Studies: The Difference

(2013) Gerard J. P. van Breukelen   MULTIVARIATE BEHAVIORAL RESEARCH

What does HDL do? A new mechanism to slow atherogenesis – But a new problem in type 2 diabetes mellitus

(2012) Kevin Jon Williams   ATHEROSCLEROSIS

High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A

(2012) Markus Tölle et al.   CARDIOVASCULAR RESEARCH

HDL functionality

(2012) Handrean Soran et al.   CURRENT OPINION IN LIPIDOLOGY

Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis

(2012) Suguru Yamamoto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients

(2011) Hirokazu Honda et al.   ATHEROSCLEROSIS

IL-1  Receptor Antagonist Reduces Inflammation in Hemodialysis Patients

(2011) A. M. Hung et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Uremia Alters HDL Composition and Function

(2011) M. Holzer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

(2010) Margarita de la Llera-Moya et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Therapeutic Targeting of Mitochondrial Superoxide in Hypertension

(2010) Anna E. Dikalova et al.   CIRCULATION RESEARCH

Importance of macrophage cholesterol content on the flux of cholesterol mass

(2010) Sandhya Sankaranarayanan et al.   JOURNAL OF LIPID RESEARCH

A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells

(2010) Peggy Robinet et al.   JOURNAL OF LIPID RESEARCH

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of freezing on high-density lipoprotein functionality

(2008) J. Rajinda Kekulawala et al.   ANALYTICAL BIOCHEMISTRY

HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 Production

(2008) Markus Tölle et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?

(2008) P. Stenvinkel et al.   Clinical Journal of the American Society of Nephrology

The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis

(2008) Mohamad Navab et al.   TRENDS IN CARDIOVASCULAR MEDICINE